{
  "docId": "019dd923-622c-750b-8b9b-9646c0061f4f",
  "docSlug": "002774f67694",
  "documentTitle": "Valeant Pharmaceuticals International (VRX)",
  "authorId": "01_Pershing_Square",
  "authorName": "William Ackman",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2015-05-04 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 36,
  "pageCount": 47,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "peer_gap",
  "function": "expose_gap",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses 'X' icons to denote negative attributes of peer groups.",
  "elementsJson": [
    "headline_text",
    "callout_box",
    "bullet_list"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9b-9646c0061f4f/36",
  "deckHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9b-9646c0061f4f#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.11,
        "w": 0.82,
        "x": 0.088,
        "y": 0.225
      },
      "kind": "callout",
      "text": "Valeant’s durable business has few peers among publicly traded pharmaceutical companies",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4f1a216-4c4a-4ebc-a088-1b7bd09a52b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.54,
        "y": 0.395
      },
      "kind": "list",
      "text": "Specialty Pharmaceuticals: High product concentration, Few durable assets",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "165d863c-739e-42fc-93c3-9bf046dafbd8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.54,
        "y": 0.635
      },
      "kind": "list",
      "text": "Generic Pharmaceuticals: Focused on commodity categories, Low secular growth",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cf27d0b-6914-4e57-aeb1-2fd5eb299bf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.35,
        "x": 0.13,
        "y": 0.67
      },
      "kind": "list",
      "text": "Biotech: High product concentration, Large R&D investment",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "227fc22d-389b-4215-b1db-5ee7770fe85f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.13,
        "y": 0.395
      },
      "kind": "list",
      "text": "Big Pharma: Few durable assets, High exposure to competitive, low-growth categories",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "430b96e3-a4bf-4a85-9719-209e1ce996e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.63,
        "x": 0.088,
        "y": 0.095
      },
      "kind": "title",
      "text": "Durable Portfolio: Few Healthcare Trading Comparables",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "400004cb-3033-43f7-8012-d1fe058d1a49",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Peer gap chart",
      "slug": "peer-gap",
      "agent": null,
      "layer": "slide",
      "matchId": "dae8b2fc-6bc4-49ae-b97f-ffc9012a93cd",
      "evidence": "Valeant’s durable business has few peers among publicly traded pharmaceutical companies",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "6465a83a-5d32-4a74-a28f-6ad793a784a4",
      "evidence": "Compares the subject company against four distinct industry segments to highlight a lack of direct peers.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}